Excellagen is indicated for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. Excellagen is contraindicated for individuals with a known sensitivity to products of bovine origin.

Excellagen is for use by healthcare professionals in the United States. All information, including the prescribing information for Excellagen, follows laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States. Detailed information about Excellagen can be found in the Package Insert and the Directions for Use.

¹Fufa D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg. 2008 Apr;66(4):684-90.
²In-vitro data on file at Cardium.